Literature DB >> 31618602

BMP Signaling in Development, Stem Cells, and Diseases of the Gastrointestinal Tract.

Yongchun Zhang1,2, Jianwen Que1,2.   

Abstract

The bone morphogenetic protein (BMP) pathway is essential for the morphogenesis of multiple organs in the digestive system. Abnormal BMP signaling has also been associated with disease initiation and progression in the gastrointestinal (GI) tract and associated organs. Recent studies using animal models, tissue organoids, and human pluripotent stem cells have significantly expanded our understanding of the roles played by BMPs in the development and homeostasis of GI organs. It is clear that BMP signaling regulates GI function and disease progression that involve stem/progenitor cells and inflammation in a tissue-specific manner. In this review we discuss these new findings with a focus on the esophagus, stomach, and intestine.

Entities:  

Keywords:  TGF-β superfamily; cancer; epithelium-mesenchymal interaction; esophagus; intestine; stomach

Year:  2019        PMID: 31618602     DOI: 10.1146/annurev-physiol-021119-034500

Source DB:  PubMed          Journal:  Annu Rev Physiol        ISSN: 0066-4278            Impact factor:   19.318


  10 in total

1.  BMP2 inhibits cell proliferation by downregulating EZH2 in gastric cancer.

Authors:  Zilu Chen; Liyue Yuan; Xiaopeng Li; Junhui Yu; Zhengshui Xu
Journal:  Cell Cycle       Date:  2022-07-20       Impact factor: 5.173

2.  Altered BMP-Smad4 signaling causes complete cleft palate by disturbing osteogenesis in palatal mesenchyme.

Authors:  Nan Li; Jing Liu; Han Liu; Shangqi Wang; Ping Hu; Hailing Zhou; Jing Xiao; Chao Liu
Journal:  J Mol Histol       Date:  2020-11-07       Impact factor: 2.611

Review 3.  Prevention of tumor risk associated with the reprogramming of human pluripotent stem cells.

Authors:  Kenly Wuputra; Chia-Chen Ku; Deng-Chyang Wu; Ying-Chu Lin; Shigeo Saito; Kazunari K Yokoyama
Journal:  J Exp Clin Cancer Res       Date:  2020-06-03

Review 4.  Obesity and intestinal stem cell susceptibility to carcinogenesis.

Authors:  Katayoun Pourvali; Hadi Monji
Journal:  Nutr Metab (Lond)       Date:  2021-04-07       Impact factor: 4.169

5.  Uncoupling the BMP receptor antagonist function from the WNT agonist function of R-spondin 2 using the inhibitory peptide dendrimer RWd.

Authors:  Hyeyoon Lee; Rui Sun; Christof Niehrs
Journal:  J Biol Chem       Date:  2022-01-12       Impact factor: 5.157

6.  Elevated Protein Kinase A Activity in Stomach Mesenchyme Disrupts Mesenchymal-epithelial Crosstalk and Induces Preneoplasia.

Authors:  Pawan Puri; Garfield Grimmett; Rawah Faraj; Laurielle Gibson; Ebony Gilbreath; Bradley K Yoder
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2022-06-09

7.  αSMA+ fibroblasts suppress Lgr5+ cancer stem cells and restrain colorectal cancer progression.

Authors:  Kathleen M McAndrews; Karina Vázquez-Arreguín; Changsoo Kwak; Hikaru Sugimoto; Xiaofeng Zheng; Bingrui Li; Michelle L Kirtley; Valerie S LeBleu; Raghu Kalluri
Journal:  Oncogene       Date:  2021-06-09       Impact factor: 8.756

8.  R-spondins are BMP receptor antagonists in Xenopus early embryonic development.

Authors:  Hyeyoon Lee; Carina Seidl; Rui Sun; Andrey Glinka; Christof Niehrs
Journal:  Nat Commun       Date:  2020-11-04       Impact factor: 14.919

9.  Stem cell and niche regulation in human short bowel syndrome.

Authors:  Vered A Gazit; Elzbieta A Swietlicki; Miranda U Liang; Adam Surti; Raechel McDaniel; Mackenzie Geisman; David M Alvarado; Matthew A Ciorba; Grant Bochicchio; Obeid Ilahi; John Kirby; William J Symons; Nicholas O Davidson; Marc S Levin; Deborah C Rubin
Journal:  JCI Insight       Date:  2020-12-03

Review 10.  Regulatory mechanisms of cytoneme-based morphogen transport.

Authors:  Christina A Daly; Eric T Hall; Stacey K Ogden
Journal:  Cell Mol Life Sci       Date:  2022-02-04       Impact factor: 9.261

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.